'Optimized' LV only pacing using a dual chamber pacemaker as a cost effective alternative to CRT
- PMID: 29073000
- PMCID: PMC5478914
- DOI: 10.1016/j.ipej.2017.05.001
'Optimized' LV only pacing using a dual chamber pacemaker as a cost effective alternative to CRT
Abstract
Background: Cardiac Resynchronization therapy (CRT) remains largely under-used in developing countries owing to the high cost of therapy. In this pilot study, we explore 'optimized' Left Ventricle Only Pacing (LVOP) as a cost effective alternative to cardiac resynchronization therapy in selected patients with heart failure.
Hypothesis: In economically poorer patients with heart failure, left bundle branch block (LBBB) and intact AV node conduction, synchronization can be obtained using a dual chamber pacemaker (leads in right atrium and Left ventricle) with the help of 2D strain imaging.
Methods and results: 4 patients underwent LVOP for symptomatic heart failure. Post procedure 'optimization' was done using 12 lead electrocardiography and 2D- Strain imaging. Difference between Time to Peak longitudinal strain and Aortic valve Closure (Diff TPL-AC) was calculated for each segment at different AV delays and the AV delay with the smallest Diff TPL-AC was programmed. The mean AV delay that resulted in electrical and mechanical synchrony was 150 ms. After a mean follow up of 6 months, all patients had improved by at least 1 NYHA class. The mean reduction in QRS duration post procedure was -54.5 ± 22.82 ms and the mean improvement in EF was 7 ± 2.75%.
Conclusion: Optimized LVOP using 2D strain and ECG can be a cost-effective alternative to CRT in patients with LBBB, heart failure and normal AV node conduction.
Keywords: Dual chamber CRT; LV only pacing; Optimized LVOP.
Copyright © 2017 Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. All rights reserved.
Figures
References
-
- Tracy C.M., Epstein A.E., Darbar D. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the american College of Cardiology foundation/american heart association task force on practice guidelines. J Am Coll Cardiol. 2012;60(14):1297–1313. - PubMed
-
- Russo A.M., Stainback R.F., Bailey S.R. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the american College of Cardiology foundation appropriate use criteria task force, heart rhythm society, american heart association, american society of echocardiography, heart failure society of America, society for cardiovascular angiography and interventions, society of cardiovascular computed tomography, and society for cardiovascular magnetic resonance. J Am Coll Cardiol. 2013;61(12):1318–1368. - PubMed
-
- Brignole M., Auricchio A., Baron-Esquivias G. ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) Europace. 2013;15(8):1070–1118. 2013 Aug. - PubMed
-
- Kass D.A., Chen C.H., Curry C. Improved left ventricular mechanics from VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation. 1999;99:1567–1593. - PubMed
-
- Blanc J.J., Etienne Y., Gilard M. Evaluation of different ventricular pacing sites in patients with severe heart failure. results of an acute hemodynamic study. Circulation. 1997;96:3273–3277. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials